PAGE5

Mutation & survival
SurvivalMutationKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, PAGE5 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated PAGE5 data layer compared with 26 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher PAGE5 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated PAGE5 expression acts as an unfavorable survival marker.

READ, SCLC, and SARC are the cancer types where PAGE5 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
READOSMedianII,III,IV0.0540.934<.00124view →
SCLCOSMedianAll0.0820.708<.00112view →
SARCDFSMedianAll0.0980.611.0066view →
COADDFSMedianAll0.2230.691.0116view →
SKCMDFSMedianII,III,IV0.1390.712<.0016view →
Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

PAGE5–READ (OS)

Kaplan–Meier survival curve for PAGE5 mutant vs wild-type samples in READ.

Open the READ breakdown →

Exploration